



Markets
/
Stocks
/
nasdaq-qgen
/

Qiagen NV

QGEN

View Detailed Chart

42.085USD

-0.975-2.26%

Close 04/25, 16:00（ET）Quotes delayed by 15 min

9.10BMarket Cap

108.81P/E TTM



Qiagen NV

42.085

-0.975-2.26%

Company

Intraday

30m

Today

-2.26%

5 Days

+3.38%

1 Month

+9.11%

6 Months

+1.30%

Year to Date

-5.48%

1 Year

+1.06%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 18 analysts

BUY

Current Rating

48.962

Target Price

16.38%

Rising Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

556

Total

Median

Average

Company name

Ratings

Analysts

Qiagen NV

QGEN

CRISPR Therapeutics AG

CRSP

Regeneron Pharmaceuticals Inc

REGN

Intellia Therapeutics Inc

NTLA

Moderna Inc

MRNA

Exact Sciences Corp

EXAS

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Neutral

Sell(5)

Neutral(4)

Buy(4)

Indicators

Sell(2)

Neutral(4)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.723

Neutral

RSI(14)

52.259

Neutral

STOCH(KDJ)(9,3,3)

61.974

Neutral

ATR(14)

1.693

Low Volatility

CCI(14)

59.335

Neutral

Williams %R

34.151

Buy

TRIX(12,20)

0.012

Sell

StochRSI(14)

55.158

Sell

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

42.054

Buy

MA10

41.825

Buy

MA20

40.740

Buy

MA50

42.641

Sell

MA100

43.084

Sell

MA200

43.515

Sell

News

More news coming soon, stay tuned...

Company

Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.

Company codeQGEN

CompanyQiagen NV

CEOMr. Thierry Bernard

Websitehttps://www.qiagen.com/